INOVIQ Annual Report 2024

21 SHARE-BASED PAYMENTS The following share-based payment arrangements existed at 30 June 2024: Number of Options Exercise Price ($) Granted Date Status Vested Date Expiry Date Conditions Note 26,000 $0.81 28-Jul-20 Vested 28-Jul-20 2-Jul-24 Yes 1 & 2 57,200 $0.81 28-Jul-20 Vested 2-Jul-21 2-Jul-24 Yes 1 & 2 47,667 $0.81 28-Jul-20 Vested 2-Jul-22 2-Jul-24 Yes 1, 2 & 3 13,000 $0.51 28-Jul-20 Vested 6-Feb-21 6-Feb-25 Yes 1 & 2 20,222 $0.51 28-Jul-20 Vested 6-Feb-22 6-Feb-25 Yes 1 & 2 166,667 $1.13 14-Apr-21 Vested 14-Apr-21 30-Apr-25 Yes 1 & 4 1,000,000 $3.00 29-Nov-21 Granted Conditions 30-Sep-24 Yes 1 & 5 50,000 $1.73 04-Jan-22 Vested 20-Sep-22 20-Sep-25 Yes 1 & 3 50,000 $1.73 04-Jan-22 Vested 20-Sep-23 20-Sep-25 Yes 1 & 3 50,000 $1.73 04-Jan-22 Granted 20-Sep-24 20-Sep-25 Yes 1 & 3 50,000 $0.82 2-Nov-22 Vested 2-Nov-23 2-Nov-26 Yes 1 & 3 50,000 $0.82 2-Nov-22 Granted 2-Nov-24 2-Nov-26 Yes 1 & 3 50,000 $0.82 2-Nov-22 Granted 2-Nov-25 2-Nov-26 Yes 1 & 3 166,667 $1.08 15-Dec-22 Vested 15-Dec-23 15-Dec-26 Yes 1 & 3 166,667 $1.08 15-Dec-22 Granted 15-Dec-24 15-Dec-26 Yes 1 & 3 166,666 $1.08 15-Dec-22 Granted 15-Dec-25 15-Dec-26 Yes 1 & 3 125,001 $0.845 28-Sep-23 Granted 28-Sep-24 28-Sep-27 Yes 1 & 3 125,000 $0.845 28-Sep-23 Granted 28-Sep-25 28-Sep-27 Yes 1 & 3 124,999 $0.845 28-Sep-23 Granted 28-Sep-26 28-Sep-27 Yes 1 & 3 1,075,000 $0.89 29-Nov-23 Vested 29-May-24 29-May-26 Yes 1 & 3 1,075,000 $0.89 29-Nov-23 Granted 29-Nov-24 29-Nov-26 Yes 1 & 3 1,075,000 $0.89 29-Nov-23 Granted 29-May-25 29-May-27 Yes 1 & 3 1,075,000 $0.89 29-Nov-23 Granted 29-Nov-25 29-Nov-27 Yes 1 & 3 1,075,000 $0.89 29-Nov-23 Granted 29-May-26 29-May-28 Yes 1 & 3 1,075,000 $0.89 29-Nov-23 Granted 29-Nov-26 29-Nov-28 Yes 1 & 3 8,955,756 Total ESOP Options Notes: 1. Issued under the terms of the INOVIQ Incentive Option Plan (ESOP). 2. Upon termination of employment, vested options expire 60 days after termination of employment other than upon death, retirement, disability, or at Board discretion. Options are to be allowed to remain exercisable until expiry upon retirement or disability. Upon death, or mental incapacity, options can be transferred to an estate, or next of kin, and allowed to remain exercisable until expiry. In case of a change of control unvested options which have not expired are deemed to have satisfied the vesting conditions. 3. Vesting basis: to remain employed by INOVIQ up until vesting date. 4. Options issued to Dr Leearne Hinch. If Dr Hinch is to leave the employment of the Group options will expire 3 months after the departure date. 5. For the options to vest (be exercisable) the 7-day volume weighted price of the Company’s Shares must reach $3.00. ESOP options are not subject to performance conditions however are subject to continuation of employment, except in the event of forced resignation due to illness/death or retirement where the Board may exercise discretion to allow unvested options to continue onto expiry. All options granted are in respect of ordinary shares in INOVIQ Limited and confer a right of one ordinary share for each option held. Per the terms and conditions of the Incentive Option Plan, directors retain the right to vary the terms of issued options as long as the variation does not result in a lessening of the holder’s rights. Notes to the Financial Statements continued for the year ended 30 June 2024 56 INOVIQ Limited

RkJQdWJsaXNoZXIy MjE2NDg3